Daniel Bouthillier
Hoofd Techniek/Wetenschap/O&O bij DEVONIAN HEALTH GROUP INC.
Actieve functies van Daniel Bouthillier
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| DEVONIAN HEALTH GROUP INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
Québec Biotechnology Innovation Centre
 Québec Biotechnology Innovation Centre BiotechnologyHealth Technology Québec Biotechnology Innovation Centre operates research and development center for biotechnology. It offers infrastructure, consulting, and funding services. The company was founded in 1995 and is headquartered in Laval, Canada. | Directeur/Bestuurslid | - | - |
| Kanyr Pharma, Inc. | Directeur/Bestuurslid | - | - |
Loopbaan van Daniel Bouthillier
Eerdere bekende functies van Daniel Bouthillier
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01-11-1994 | 01-08-2010 |
Clinical Research Institute of Montreal
 Clinical Research Institute of Montreal Miscellaneous Commercial ServicesCommercial Services The Clinical Research Institute of Montreal engages in clinical research. | Hoofd Administratief Officier | - | - |
Génome Québec, Inc.
 Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Directeur/Bestuurslid | - | - |
| Kaneq Pharma, Inc. | Oprichter | - | - |
Kaneq Bioscience Ltd.
 Kaneq Bioscience Ltd. BiotechnologyHealth Technology Kaneq Bioscience Ltd. operates as a biotechnology company focuses on developing treatments for type 2 diabetes. The firm develops a protein tyrosine phosphatase1B inhibitor for treating type 2 diabetes mellitus. The company was founded by Jean Bourgouin on October 19, 2012 and is headquartered in Montreal, Canada. | Algemeen Directeur | 19-10-2012 | - |
| Oprichter | 19-10-2012 | - | |
| President | 19-10-2012 | - |
Opleiding van Daniel Bouthillier
| University of Montréal | Doctorate Degree |
| HEC Montréal | Masters Business Admin |
Statistieken
Internationaal
| Canada | 10 |
| Verenigde Staten | 2 |
Operationeel
| Director/Board Member | 3 |
| Founder | 2 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| DEVONIAN HEALTH GROUP INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Génome Québec, Inc.
Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
Clinical Research Institute of Montreal
Clinical Research Institute of Montreal Miscellaneous Commercial ServicesCommercial Services The Clinical Research Institute of Montreal engages in clinical research. | Commercial Services |
Québec Biotechnology Innovation Centre
Québec Biotechnology Innovation Centre BiotechnologyHealth Technology Québec Biotechnology Innovation Centre operates research and development center for biotechnology. It offers infrastructure, consulting, and funding services. The company was founded in 1995 and is headquartered in Laval, Canada. | Health Technology |
Kaneq Bioscience Ltd.
Kaneq Bioscience Ltd. BiotechnologyHealth Technology Kaneq Bioscience Ltd. operates as a biotechnology company focuses on developing treatments for type 2 diabetes. The firm develops a protein tyrosine phosphatase1B inhibitor for treating type 2 diabetes mellitus. The company was founded by Jean Bourgouin on October 19, 2012 and is headquartered in Montreal, Canada. | Health Technology |
| Kanyr Pharma, Inc. | |
| Kaneq Pharma, Inc. |
- Beurs
- Insiders
- Daniel Bouthillier
- Ervaring